This promotional site has been created by Britannia Pharmaceuticals Ltd. and is intended for healthcare professionals based in countries where LECIGON® (levodopa, carbidopa, entacapone) has marketing authorisation. UK LECIGON® Prescribing Information and Adverse Event Reporting can be found here (external non-Britannia website)

Unveiling the full NefIgArd trial results and ASN 2023 highlights

November 9th, 2024 10:00-12:00 CET

Moderated by:

Prof. Barratt (UK)

Prof. Floege (DE)

22nd May, 2025 18:00-19:00 CET

Join EventWatch RecordingNeuro Summit - September 2025

Neuro Summit 2 coming soon